Agency Information Collection Activities: Proposed Collection; Comment Request, 22170-22172 [2020-08364]
Download as PDF
<![CDATA[
22170
Federal Register / Vol. 85, No. 77 / Tuesday, April 21, 2020 / Notices
FEDERAL RESERVE SYSTEM
lotter on DSKBCFDHB2PROD with NOTICES
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
The notificants listed below have
applied under the Change in Bank
Control Act (Act) (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
applications are set forth in paragraph 7
of the Act (12 U.S.C. 1817(j)(7)).
The applications listed below, as well
as other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank indicated. The
applications will also be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
standards enumerated in paragraph 7 of
the Act.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington DC 20551–0001, not later
than May 6, 2020.
A. Federal Reserve Bank of New York
(Ivan Hurwitz, Senior Vice President) 33
Liberty Street, New York, New York
10045–0001. Comments can also be sent
electronically to
Comments.applications@ny.frb.org:
1. Phillippe D. Katz, Esther Katz, Isaac
S. Katz, Maxwell T. Katz, Kara Z.
Newman and Charlotte Cohen, all of
Lawrence, New York; Austin J. Katz of
Clifton, New Jersey; Marga Marx, Joseph
M. Fink, Eva Fink, Moshe Aaron Fink,
Eric Dov Fink, Elliot Meir Fink, Hillary
Fink Rosenberg and Kaethe Fink Feit, all
of New York, New York; KF Investors
LLC, and Momar Corporation, both of
New York, New York, and both with Eva
Fink and Ester Katz, as principal
shareholders; Marneu Holding
Company, New York, New York, the
general partners of which are Moses
Marx, Bronx, New York (who has
previously received permission to
control the bank holding company and
bank listed below) and United Equity
Reality Associates, New York, New
York, (the principal shareholders of
which are Moses Marx, Joseph M. Fink,
and Phillip D. Katz); Terumah
Foundation, Inc., New York, New York,
Moses Marx, Marga Marx, Eva Fink,
Joseph M. Fink, Esther Katz and
Philippe D. Katz, as directors; and
United Equities Commodities Company,
New York, New York, Moses Marx,
VerDate Sep<11>2014
21:19 Apr 20, 2020
Jkt 250001
Joseph M. Fink, and Phillip D. Katz, as
general partners; as members of a group
acting in concert with Moses Marx to
retain voting shares of Berkshire
Bancorp Inc. and thereby indirectly
retain voting shares of The Berkshire
Bank, both of New York, New York.
Board of Governors of the Federal Reserve
System, April 16, 2020.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2020–08404 Filed 4–20–20; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, HHS.
AGENCY:
ACTION:
Notice.
This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project
‘‘Evaluation of the SHARE Approach
Model.’’
This proposed information collection
was previously published in the Federal
Register on February 4, 2020, and
allowed 60 days for public comment.
AHRQ did not receive comments from
members of the public. The purpose of
this notice is to allow an additional 30
days for public comment.
SUMMARY:
Comments on this notice must be
received by 30 days after date of
publication of this notice.
DATES:
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
email at doris.lefkowitz@AHRQ.hhs.gov
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Proposed Project
Evaluation of the SHARE Approach
Model
Shared decision making (SDM) occurs
when a health care provider and a
patient work together to make a health
care decision that is best for the patient.
Implementing SDM involves effective
communication between providers and
patients to take into account evidencebased information about available
options, the provider’s knowledge and
experience, and the patient’s values and
preferences in reaching the best health
care decision for a patient. To facilitate
SDM in all care delivery settings, AHRQ
developed the five-step SHARE
Approach, which includes exploring
and comparing the benefits, harms, and
risks of each option through meaningful
dialogue about what matters most to the
patient. Using the SHARE Approach
also builds a trusting and lasting
relationship between health care
professionals and patients.
SDM is increasingly included in
clinical care guidelines, and in some
cases is even mandated. While there is
considerable interest in improving SDM
across broad health care settings, less is
known about how to effectively
implement SDM. There is evidence that
SDM is often not conducted effectively
in practice, and identifying ways to
improve SDM has therefore become an
imperative. Lack of clinician support
and education have been identified as
important barriers to SDM.
The SHARE Approach was released in
2015 by AHRQ as a clinician-facing
toolkit that teaches clinicians skills to
facilitate SDM across a broad range of
clinical contexts. While several
implementation success stories have
been shared with AHRQ, to date there
has been no formal evaluation of the
effectiveness of the SHARE Approach
materials for improving SDM in primary
and specialty care settings for which it
was designed. As a result, challenges
that may be faced by practices who wish
to implement the SHARE Approach are
currently unknown. Without research to
identify and address these issues,
practices and organization may be
unable to effectively implement the
SHARE Approach and may be unwilling
to do so absent evidence of its
effectiveness at improving SDM
outcomes.
The Evaluation of the SHARE
Approach Model project aims to revise
the SHARE Approach toolkit to remove
outdated references and increase
applicability for SDM in contexts
involving problem solving, evaluate the
implementation of the SHARE
Approach model in eight primary care
E:\FR\FM\21APN1.SGM
21APN1
22171
Federal Register / Vol. 85, No. 77 / Tuesday, April 21, 2020 / Notices
and four cardiology clinics, and
evaluate the effectiveness of the SHARE
Approach model at improving SDM.
Method of Collection
The purpose of this clearance request
is to collect the information needed to
evaluate the implementation and
effectiveness of the modified SHARE
Approach materials. Specifically, the
data collection activities requested in
this clearance are:
1. Brief surveys of physicians,
advanced practice providers, other
clinicians, nurses and other staff in 12
clinics immediately following the
SHARE Approach training in each
clinic.
2. A brief survey of physicians,
advanced practice providers, other
clinicians, nurses and other staff in 12
clinics one month following the SHARE
Approach training in each clinic.
3. A short card survey completed by
patients in the 12 clinics immediately
following a clinic visit with a physician
or advanced practice provider.
4. A short card survey completed by
physicians or advanced practice
providers in the 12 clinics immediately
following a clinic visit with a patient.
5. Audio recordings of patientprovider (physician or advanced
practice provider) encounters in clinic
examination rooms in the 12 clinics.
This study is being conducted by
AHRQ through its contractor, the
University of Colorado, pursuant to
AHRQ’s statutory authority to conduct
and support research on health care and
on systems for the delivery of such care,
including activities with respect to
clinical practice, including primary care
and practice-oriented research. 42 U.S.C
299a(a)(4).
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated burden
hours for the respondents’ time to
participate in the research activities that
will be conducted under this clearance.
Data collection will occur between
September 2020 and October 2021.
Surveys of physicians, advanced
practice providers, other clinicians,
nurses and other staff in each of the 12
practices will be conducted at the time
of SHARE training and again
approximately 1 to 2 months following
training. These will be conducted with
no more than 100 physicians, advanced
practice providers, other clinicians,
nurses and other staff for each survey
and will require no more than 10
minutes to complete.
Brief card surveys will be completed
by both patients and clinicians. We
estimate the maximum number of
patients participating in the card survey
as follows: A maximum of 100
clinicians will see a maximum of 20
patients per day, of which half (n = 10)
will agree to complete the card survey,
over 6 days of data collection, totaling
N = 6,000 patient respondents (100 × 10
× 6). The patient card survey will take
a maximum of 2 minutes per completed
survey. Clinicians will complete a card
survey for every patient they see during
the 6 days of data collection, or a total
of N = 12,000 card surveys (100
clinicians × 20 patients per day × 6
days). The clinician card survey will
require a maximum of 1 minute per
completed survey.
Audio recordings of up to 260 clinical
encounters will be obtained with
burden not to exceed 10 minutes to
obtain patient informed consent.
EXHIBIT 1—ESTIMATED RESPONDENT BURDEN HOURS
Number of
respondents
Type of information collection
Number of
responses per
respondent
Hours per
response
Total burden
hours
Card survey (patient) .......................................................................................
Card survey (clinician) .....................................................................................
Audio recorded encounters .............................................................................
Clinician survey * ..............................................................................................
6,000
100
260
100
1
120
1
2
2/60
1/60
10/60
10/60
200
200
44
34
Totals ........................................................................................................
6,460
na
na
478
* May include telephone non-response follow-up in which case the burden will not change.
Exhibit 2 shows the estimated cost
burden of respondents for these data
collection activities, based on the
respondent’s time to participate in these
data collection activities. The total cost
burden is estimated to be $29,831.
EXHIBIT 2—ESTIMATED COST BURDEN
Number of
respondents
Type of Information collection
Total burden
hours
Average
hourly
wage rate *
Total cost
burden
Card survey (patient) .......................................................................................
Card survey (clinician) .....................................................................................
Audio recorded encounters .............................................................................
Clinician survey ................................................................................................
6,000
100
260
100
200
200
44
34
$24.98
101.43
24.98
101.43
$4,996
20,286
1,100
3,449
Totals ........................................................................................................
6,460
478
na
29,831
lotter on DSKBCFDHB2PROD with NOTICES
* Based upon the average wages for 29–1060 Physicians and Surgeons (broad) and 00–0000 All Occupations, ‘‘National Compensation Survey: Occupational Wages in the United States, May 2018,’’ U.S. Department of Labor, Bureau of Labor Statistics https://www.bls.gov/oes/current/
oes_nat.htm#29-0000.
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
VerDate Sep<11>2014
21:19 Apr 20, 2020
Jkt 250001
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ’s health care
research and health care information
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
E:\FR\FM\21APN1.SGM
21APN1
22172
Federal Register / Vol. 85, No. 77 / Tuesday, April 21, 2020 / Notices
collection(s) of information; (c) ways to
enhance the quality, utility and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: April 15, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020–08364 Filed 4–20–20; 8:45 am]
lotter on DSKBCFDHB2PROD with NOTICES
BILLING CODE 4160–90–P
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Room 3An12N, 45 Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ruth Grossman, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN18, Bethesda, MD
20892, (301) 435–2409, grossmanrs@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: April 15, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2020–08362 Filed 4–20–20; 8:45 am]
Scientific Review, Division of Extramural
Activities, NCCIH, NIH, 6707 Democracy
Boulevard, Suite 401, Bethesda, MD 20892–
5475, jessica.mcklveen@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: April 16, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–08439 Filed 4–20–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
[Docket No. CISA–2020–0003]
Notice of President’s National Security
Telecommunications Advisory
Committee Meeting
National Institute of General Medical
Sciences; Notice of Closed Meetings
BILLING CODE 4140–01–P
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Cybersecurity and
Infrastructure Security Agency (CISA),
Department of Homeland Security
(DHS).
ACTION: Notice of Federal Advisory
Committee Act (FACA) meeting; request
for comments.
National Institutes of Health
SUMMARY:
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of NIGMS SCORE
Applications.
Date: June 18, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Room 3AN12, 45 Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sonia Ortiz-Miranda,
Ph.D., Scientific Review Officer, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3AN18,
Bethesda, MD 20892, (301) 402–9448,
sonia.ortiz-miranda@nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of NIGMS COBRE Phase 1
Applications.
Date: June 18–19, 2020.
Time: 8:00 a.m. to 6:00 p.m.
VerDate Sep<11>2014
21:19 Apr 20, 2020
Jkt 250001
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Center of Excellence
for Research on Complementary and
Integrative Health (P01) (CERCIH).
Date: May 21, 2020.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Jessica Marie McKlveen,
Ph.D., Scientific Review Officer, Office of
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
AGENCY:
CISA is publishing this notice
to announce the following President’s
National Security Telecommunications
Advisory Committee (NSTAC) meeting.
This meeting will be partially closed to
the public.
DATES:
Meeting Registration: Registration to
attend the meeting is required and must
be received no later than 5:00 p.m.
Eastern Time (ET) on May 6, 2020. For
more information on how to participate,
please contact NSTAC@hq.dhs.gov.
Speaker Registration: Registration to
speak during the meeting’s public
comment period must be received no
later than 5:00 p.m. ET on May 6, 2020.
Written Comments: Written comments
must be received no later than 5:00 p.m.
ET on May 6, 2020.
Meeting Date: The NSTAC will meet
on May 13, 2020, from 12:00 p.m. to
2:30 p.m. ET. The meeting may close
early if the committee has completed its
business.
ADDRESSES: The meeting will be held
via conference call. For access to the
conference call bridge, information on
services for individuals with
disabilities, or to request special
assistance, please email NSTAC@
hq.dhs.gov by 5:00 p.m. ET on May 6,
2020.
Comments: Members of the public are
invited to provide comment on the
issues that will be considered by the
E:\FR\FM\21APN1.SGM
21APN1
]]>Agencies
[Federal Register Volume 85, Number 77 (Tuesday, April 21, 2020)]
[Notices]
[Pages 22170-22172]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08364]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the intention of the Agency for
Healthcare Research and Quality (AHRQ) to request that the Office of
Management and Budget (OMB) approve the proposed information collection
project ``Evaluation of the SHARE Approach Model.''
This proposed information collection was previously published in
the Federal Register on February 4, 2020, and allowed 60 days for
public comment. AHRQ did not receive comments from members of the
public. The purpose of this notice is to allow an additional 30 days
for public comment.
DATES: Comments on this notice must be received by 30 days after date
of publication of this notice.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427-1477, or by email at
[email protected]
SUPPLEMENTARY INFORMATION:
Proposed Project
Evaluation of the SHARE Approach Model
Shared decision making (SDM) occurs when a health care provider and
a patient work together to make a health care decision that is best for
the patient. Implementing SDM involves effective communication between
providers and patients to take into account evidence-based information
about available options, the provider's knowledge and experience, and
the patient's values and preferences in reaching the best health care
decision for a patient. To facilitate SDM in all care delivery
settings, AHRQ developed the five-step SHARE Approach, which includes
exploring and comparing the benefits, harms, and risks of each option
through meaningful dialogue about what matters most to the patient.
Using the SHARE Approach also builds a trusting and lasting
relationship between health care professionals and patients.
SDM is increasingly included in clinical care guidelines, and in
some cases is even mandated. While there is considerable interest in
improving SDM across broad health care settings, less is known about
how to effectively implement SDM. There is evidence that SDM is often
not conducted effectively in practice, and identifying ways to improve
SDM has therefore become an imperative. Lack of clinician support and
education have been identified as important barriers to SDM.
The SHARE Approach was released in 2015 by AHRQ as a clinician-
facing toolkit that teaches clinicians skills to facilitate SDM across
a broad range of clinical contexts. While several implementation
success stories have been shared with AHRQ, to date there has been no
formal evaluation of the effectiveness of the SHARE Approach materials
for improving SDM in primary and specialty care settings for which it
was designed. As a result, challenges that may be faced by practices
who wish to implement the SHARE Approach are currently unknown. Without
research to identify and address these issues, practices and
organization may be unable to effectively implement the SHARE Approach
and may be unwilling to do so absent evidence of its effectiveness at
improving SDM outcomes.
The Evaluation of the SHARE Approach Model project aims to revise
the SHARE Approach toolkit to remove outdated references and increase
applicability for SDM in contexts involving problem solving, evaluate
the implementation of the SHARE Approach model in eight primary care
[[Page 22171]]
and four cardiology clinics, and evaluate the effectiveness of the
SHARE Approach model at improving SDM.
Method of Collection
The purpose of this clearance request is to collect the information
needed to evaluate the implementation and effectiveness of the modified
SHARE Approach materials. Specifically, the data collection activities
requested in this clearance are:
1. Brief surveys of physicians, advanced practice providers, other
clinicians, nurses and other staff in 12 clinics immediately following
the SHARE Approach training in each clinic.
2. A brief survey of physicians, advanced practice providers, other
clinicians, nurses and other staff in 12 clinics one month following
the SHARE Approach training in each clinic.
3. A short card survey completed by patients in the 12 clinics
immediately following a clinic visit with a physician or advanced
practice provider.
4. A short card survey completed by physicians or advanced practice
providers in the 12 clinics immediately following a clinic visit with a
patient.
5. Audio recordings of patient-provider (physician or advanced
practice provider) encounters in clinic examination rooms in the 12
clinics.
This study is being conducted by AHRQ through its contractor, the
University of Colorado, pursuant to AHRQ's statutory authority to
conduct and support research on health care and on systems for the
delivery of such care, including activities with respect to clinical
practice, including primary care and practice-oriented research. 42
U.S.C 299a(a)(4).
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated burden hours for the respondents'
time to participate in the research activities that will be conducted
under this clearance. Data collection will occur between September 2020
and October 2021. Surveys of physicians, advanced practice providers,
other clinicians, nurses and other staff in each of the 12 practices
will be conducted at the time of SHARE training and again approximately
1 to 2 months following training. These will be conducted with no more
than 100 physicians, advanced practice providers, other clinicians,
nurses and other staff for each survey and will require no more than 10
minutes to complete.
Brief card surveys will be completed by both patients and
clinicians. We estimate the maximum number of patients participating in
the card survey as follows: A maximum of 100 clinicians will see a
maximum of 20 patients per day, of which half (n = 10) will agree to
complete the card survey, over 6 days of data collection, totaling N =
6,000 patient respondents (100 x 10 x 6). The patient card survey will
take a maximum of 2 minutes per completed survey. Clinicians will
complete a card survey for every patient they see during the 6 days of
data collection, or a total of N = 12,000 card surveys (100 clinicians
x 20 patients per day x 6 days). The clinician card survey will require
a maximum of 1 minute per completed survey.
Audio recordings of up to 260 clinical encounters will be obtained
with burden not to exceed 10 minutes to obtain patient informed
consent.
Exhibit 1--Estimated Respondent Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Type of information collection Number of responses per Hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
Card survey (patient)........................... 6,000 1 2/60 200
Card survey (clinician)......................... 100 120 1/60 200
Audio recorded encounters....................... 260 1 10/60 44
Clinician survey *.............................. 100 2 10/60 34
---------------------------------------------------------------
Totals...................................... 6,460 na na 478
----------------------------------------------------------------------------------------------------------------
* May include telephone non-response follow-up in which case the burden will not change.
Exhibit 2 shows the estimated cost burden of respondents for these
data collection activities, based on the respondent's time to
participate in these data collection activities. The total cost burden
is estimated to be $29,831.
Exhibit 2--Estimated Cost Burden
----------------------------------------------------------------------------------------------------------------
Number of Total burden Average hourly Total cost
Type of Information collection respondents hours wage rate * burden
----------------------------------------------------------------------------------------------------------------
Card survey (patient)........................... 6,000 200 $24.98 $4,996
Card survey (clinician)......................... 100 200 101.43 20,286
Audio recorded encounters....................... 260 44 24.98 1,100
Clinician survey................................ 100 34 101.43 3,449
---------------------------------------------------------------
Totals...................................... 6,460 478 na 29,831
----------------------------------------------------------------------------------------------------------------
* Based upon the average wages for 29-1060 Physicians and Surgeons (broad) and 00-0000 All Occupations,
``National Compensation Survey: Occupational Wages in the United States, May 2018,'' U.S. Department of Labor,
Bureau of Labor Statistics https://www.bls.gov/oes/current/oes_nat.htm#29-0000.
Request for Comments
In accordance with the Paperwork Reduction Act, comments on AHRQ's
information collection are requested with regard to any of the
following: (a) Whether the proposed collection of information is
necessary for the proper performance of AHRQ's health care research and
health care information dissemination functions, including whether the
information will have practical utility; (b) the accuracy of AHRQ's
estimate of burden (including hours and costs) of the proposed
[[Page 22172]]
collection(s) of information; (c) ways to enhance the quality, utility
and clarity of the information to be collected; and (d) ways to
minimize the burden of the collection of information upon the
respondents, including the use of automated collection techniques or
other forms of information technology.
Comments submitted in response to this notice will be summarized
and included in the Agency's subsequent request for OMB approval of the
proposed information collection. All comments will become a matter of
public record.
Dated: April 15, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020-08364 Filed 4-20-20; 8:45 am]
BILLING CODE 4160-90-P
